CS logo
small CS logo
UHToulouse

Toulouse, France
City in France

About UHToulouse


Toulouse, capital of France’s southern Occitanie region, is bisected by the Garonne River and sits near the Spanish border. It’s known as La Ville Rose (‘The Pink City’) due to the terra-cotta bricks used in many of its buildings. Its 17th-century Canal du Midi links the Garonne to the Mediterranean Sea, and can be traveled by boat, bike or on foot. ― Google
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
University Hospital, Toulouse
25
Total Rows: 1

Clinical Trials at UHToulouse


During the past decade, UHToulouse conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years4400003311553300000000000000Started TrialsCompleted Trails20152016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study on the Appropriateness of Bariatric Surgery in Adolescents
2009-10-01
2013-10-01
Terminated
10
Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS
2013-09-01
2017-07-01
Completed
211
Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies
2012-05-01
2020-06-01
Completed
21
Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT
2014-01-01
2019-12-01
Completed
160
Transcutaneous Electrical Nerve Stimulation (TENS) for Lower Urinary Tract Disorders in Parkinson's Syndrome
2015-04-01
2020-10-21
Completed
110
Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade Glioma
2010-06-01
2014-12-01
Completed
93
Simulect Versus ATG in Sensitized Renal Transplant Patient
2013-09-01
2017-01-01
Completed
60
Identification of the Blood Microbiota in Patient Suffering From Myocardial Infraction
2013-07-01
2015-12-01
Completed
202

Rows per page:

1–25 of 25

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "UHToulouse" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "French Association for Research on Multiple Sclerosis" with 1 trials as a collaborator, "MSD France" with 1 trials as a collaborator, "Ministry of Health, France" with 1 trials as a collaborator and "Neovii Biotech" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversity Hospital, Toulouse: 25University Hospital, Toulouse: 25

Created with Highcharts 11.1.0Top CollaboratorsAstraZeneca: 1AstraZeneca: 1French Association forResearch on MultipleSclerosis: 1French Association forResearch on MultipleSclerosis: 1MSD France: 1MSD France: 1Ministry of Health, France: 1Ministry of Health, France: 1Neovii Biotech: 1Neovii Biotech: 1Novartis: 1Novartis: 1

Clinical Trials Conditions at UHToulouse


According to Clinical.Site data, the most researched conditions in "UHToulouse" are "Anesthesia" (2 trials), "Anterior Cruciate Ligament Reconstruction" (1 trials), "Asthma Chronic" (1 trials), "Cardiomyopathies" (1 trials) and "Cirrhosis" (1 trials). Many other conditions were trialed in "UHToulouse" in a lesser frequency.

Clinical Trials Intervention Types at UHToulouse


Most popular intervention types in "UHToulouse" are "Other" (13 trials), "Drug" (5 trials), "Procedure" (3 trials), "Diagnostic Test" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "telemedicine" (2 trials), "ATG Fresenius" (1 trials), "Anterior Cruciate Ligament reconstruction (ACLR)" (1 trials), "Arm Activity Measure (ArmA) in french" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at UHToulouse


The vast majority of trials in "UHToulouse" are 24 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at UHToulouse


Currently, there are NaN active trials in "UHToulouse". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in UHToulouse, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in UHToulouse, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 9Not Applicable: 9Phase 3: 1Phase 3: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 13Completed: 13Unknown status: 7Unknown status: 7Active, not recruiting: 2Active, not recruiting: 2Terminated: 2Terminated: 2Withdrawn: 1Withdrawn: 1